About
Founder, Nordic Trial Partners
Senior clinical research consultant with 15+ years of global experience. Specialising in clinical operations, study start-up and site monitoring across Sweden, Norway and Denmark.
David Antonsson
Background
David Antonsson provides operational clinical research services across Scandinavia. With dual Master's degrees in Pharmacy and Business Administration, he brings both scientific rigour and commercial awareness to every engagement.
His career spans pharmaceutical and medical device clinical trials at every phase, from early-stage studies through to post-market surveillance and regulatory market authorisation submissions. He has worked with international CROs, biotech companies and major pharmaceutical sponsors, consistently delivering complex programmes to scope, budget and timelines.
David operates across all three Scandinavian countries, covering Sweden, Norway and Denmark locally. This tri-country coverage is unusual in the market, where most consultants work within a single national boundary. He is fluent in Swedish, English, Norwegian and Danish.
His clients value speed. Contracts are finalised and work started within days. Communication is direct, transparent and continuous. There are no hidden costs, no coordination delays and no junior staff.
Nordic Trial Partners is now preparing to grow from a single-consultant practice to a small team of clinical development specialists, extending the same senior-led, responsive model across a wider range of engagements.
Education
Certified Board Member
Swedish Academy of Board Directors, 2025MSc Business Administration
Gothenburg University, 2007-2012MSc Pharmacy
Uppsala University, 2002-2007Clinical Drug Development
Uppsala University, 2006
Languages
Swedish Native
English Fluent
Norwegian Fluent
Danish Fluent
— Career
Main Professional Experience
2021 - 2026
Major Pharmaceutical Company
Global Clinical Operations Program Director
Led cross-functional teams in the planning and delivery of clinical programmes. Scope, quality, budget, timeline and risk management. Including regulatory market authorisation submissions and lifecycle management.
2016 - 2021
Major Medical Devices Manufacturer
Senior Global Clinical Project Manager
Strategic and operational clinical project management of multinational pre- and post-market clinical trials in urology and enterology. Site monitoring. Leading and mentoring staff and overseeing vendors. ISO 14155 advisor. Leading cross-functional projects such as implementation of GDPR, EU MDR and new ISO 14155:2020, including related SOP development (clinical investigations and EU MDR clinical related).
2015
International CRO
Clinical Research Manager
Operational clinical project management of a large multinational Phase II study within a paediatric orphan liver disease, for a biotech sponsor. Data was delivered ahead of time for a drug which later ended up market authorized. Study start-up in Sweden and Denmark. Vendor oversight.
2012 - 2015
TFS Trial Form Support
Senior Clinical Research Associate
Study management, study start-up in Sweden, Norway and Denmark and site monitoring of phase II-IV and non-interventional studies. Mentoring staff.
2012
Antonsson Clinical Research Solutions
Founded
Established the consultancy to provide clinical operations, study start-up and site monitoring services across Scandinavia.
2011 - 2012
Smerud Medical Research
Clinical Research Associate
Complete responsibility for all clinical operations in Norway, including study management, study start-up and site monitoring. Phase II and IV studies in neurology and in-vitro fertilisation.
2009 - 2010
Pharma Consulting Group
Clinical Research Associate
Study start-up for Sweden and site monitoring. Business development including client acquisition.
— Expertise
Therapeutic Areas
Experience across a broad range of therapeutic areas, from Phase I through to post-market surveillance.
Oncology
Phase I-III. Multiple myeloma, colorectal, lymphoma
Respiratory
Phase I-II. COPD, asthma.
Cardiovascular
Phase I-III. Giant cell arteritis, heart failure, ICD devices.
Urology
Pre- and post-market. Urinary catheter devices.
Orphan Diseases
Phase II-III. PFIC, Fabry, achondroplasia.
Ophthalmology
Phase II. Wet age-related macular degeneration.
Neurology
Phase I-III. Multiple sclerosis, Alzheimer's.
Orthopaedics
Phase II-III. Knee implants, hand surgery.
Need Clinical Research Support?
Get in touch to discuss your project. Typically responds within 24 hours.